Navigation Links
Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
Date:7/9/2009

WAYNE, N.J., July 9 /PRNewswire/ -- Today, Bayer HealthCare Pharmaceuticals launched the BayCuff(TM) self-infusion training program, an educational initiative designed to make infusion of recombinant factor VIII easier for both patients with hemophilia A and for their caregivers. The centerpiece of the program is an adjustable cuff worn on the hand or arm that allows patients to practice the technique of self-injection without actually infusing themselves and helps caregivers learn to administer home infusions for others.

The program was developed to provide members of the hemophilia A community a life-like experience and give them skills, knowledge and confidence as they progress toward self-administration of their therapy. It helps patients rely more on themselves than family members or a nurse to receive their factor therapy, and thus feel more in control of their condition. It is recommended that patients initially use BayCuff with the assistance of a caregiver or healthcare professional.

Hemophilia A is a genetic condition characterized by missing or reduced levels of the blood clotting protein factor VIII leading to prolonged or uncontrolled bleeding episodes. Treatment of this disease may require the infusion of factor VIII therapy sometimes once, twice or three times per week. Until they can learn to infuse themselves, patients receive these infusions either from a parent or nurse. The BayCuff self-infusion training program provides the tools and educational materials needed to teach children how to self-inject in a manner that is both safe and secure. In addition, feedback from the hemophilia community has indicated that BayCuff could be utilized by caregivers who occasionally need to help adult patients infuse themselves.

"The idea for BayCuff was the result of 10 years of working with boys with hemophilia A and their families," said Tessa Speller RN, formerly of the Henry Ekert Hemophilia
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola
2. Bayer Diabetes Care Launches A1CNow(R) SELFCHECK, a New A1C Monitor for At-Home Use
3. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
4. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
5. Bayer to Present Data on Development Compound BAY 73-4506 at 45th Annual Meeting of the American Society of Clinical Oncology
6. Now Available: Bayer Diabetes Cares CONTOUR(R) Meters in Midnight Blue and Orange Burst
7. Bayer CropScience Welcomes New Emergency Services Leader to the Institute Site
8. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
9. Bayer HealthCare Marks 20th Anniversary of World Hemophilia Day With Euro 250,000 Contribution to the World Federation of Hemophilia
10. Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
11. Bayer Awards $200,000 to National Science Teachers Association to Nurture Early-Career Science Teachers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
...S Board, TORONTO, April 21 /PRNewswire-FirstCall/...der of products and services to the global life,sc...pivy, Partner at,ValueAct Capital, and Mr. William...look forward to benefiting from the,breadth of exp...
...lp or neck appear less likely to survive for five ...s, according to a report in the April issue of Arc...rnals. , Melanoma rates continue to increase whil...rognosis has been debated for decades, the authors...
...ing focus on hospital-physician ... /PRNewswire/ - The Deloitte Forensic Center repor...tions continues to get more,complex for hospitals...., that hospitals or the physicians,they enter into...
...ouncil is pleased to announce that the winner of t...Human Rights is Dr. Binayak Sen of Raipur,Chhattis...sh a hospital serving poor mine,workers in the reg...r nearly a year without trial as a result of,alleg...
...ncies diagnosed on face, ears, study finds , ... deadly melanoma skin cancers occur on the scalp a...apel Hill (UNC) study. , Researchers analyzed 51,7...where on the body, including the face or ears. , T...
...tion, BIRMINGHAM, Ala., April 21 Surgical Care A...ayek has been named president and,chief executive ...dent and,chief executive officer, Mike Snow, is re... served as president of VillageHealth Inc., an,ins...
Other Medicine News:Health News:MDS Appoints Two New Directors 2Health News:MDS Appoints Two New Directors 3Health News:Survival rates appear lower for scalp and neck melanoma than for other sites 2Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 2Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 3Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 4Health News:Video: Antifraud Compliance Getting More Complex for Hospitals 5Health News:Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights 2Health News:Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights 3Health News:Melanomas on Scalp and Neck More Deadly 2Health News:SCA Names Andrew Hayek as New President and CEO 2
(Date:12/4/2009)STREAMWOOD, Ill., Dec. 4 Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 1New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 2New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 3New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 4New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 5New Lumension Endpoint Management and Security Suite To Deliver End to End Endpoint Management Capabilities 62352 6Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 1US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 2US Farms Inc Announces Marketing Agreement With Micro Lending Institution Angels In Action 62347 3
...eague,s historic Personhood Conference is featurin...earch and regenerative medicine. , , (Logo: htt...OGO ) , , Dr. Theresa Deisher, founder and CEO o...Pharmaceutical Institute, is speaking on over 17 y...ry, production and commercialization of human ther...
...x Foundation for Parkinson,s Research awarded abou... will test drugs already approved in other disease...son,s disease. Because both drugs being tested are...tential to move swiftly toward regulatory approval...ective in PD. , , One funded team will investigat...
Other Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials 2
... Orthosis Until now, laborious custom fabrication ...tability was limited and modifications in response...d cumbersome.,The GunSlinger evolved from two yea...ching hospital. This orthosis can be quickly adjus...
...gned for the functional management of grade I, II,...e-inflated aircell, the brace provides focused, pn... while supporting the arm and shoulder. A detachab...additional arm support and helps to unload the wai...
...to treat or help prevent lower extremity disorder..., foot drop, contractures and pressure necrosis at...s a comfortable wicking interface for the patient....ed into a vertical configuration when not needed o...
... ankle. This simple concept is the cornerstone of ... you lock the heel with our patent-pending Stablel...d comfort your patient will experience walking in ...the heel and supports the posterior aspect of the ...
Medicine Products: